h.ramos
TL2 · Genoa
Contributes reviews on supplier material. Based in Genoa.
Joined 24 May 2025 · last posted 8d
73 posts, newest first. Showing up to 150.
-
Designing a personal experiment that could change your mind — one year on Replied, post #78 · Research Methods › N-of-1 designs · 20 Jul 2026 · 0 likes Taking Designing a personal experiment seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #42 · Practice › Side effects · 10 Jul 2026 · 5 likes A note on how Muscle cramps gets discussed rather than on Muscle cramps itself: the confident posts get the replies and the careful ones get ignored, and the careful…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #70 · Analytics › Home & field testing · 10 Jul 2026 · 0 likes Post #69 answers the question as asked. The question underneath it is different. Source for the consumer-accessible tests figure, since it was asked for. It is in the…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #12 · Analytics › HPLC & UHPLC · 4 Jul 2026 · 0 likes Post #11 put the caveat in the right place and I want to underline it. Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains…
-
Deamidation and the close-eluting pair it produces — the long version Replied, post #4 · Analytics › Impurities & related substances · 4 Jul 2026 · 0 likes Reading back through the Deamidation threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That…
-
A structured critique template this community uses — a second dataset Replied, post #21 · Evidence › Study critique · 27 Jun 2026 · 4 likes I have been on both sides of the structured critique template argument in this category within eighteen months, which should tell you how strong the evidence for either…
-
Insurance and replacement policies, compared Replied, post #44 · Sourcing › Logistics · 26 Jun 2026 · 4 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #95 · Evidence › Journal club · 23 Jun 2026 · 0 likes On indirect comparison the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Micronutrient adequacy at low total intake Replied, post #70 · Nutrition & Training › Protein & intake · 12 Jun 2026 · 1 like Building on post #67 rather than restating it. Checked the micronutrient adequacy claim against the primary source this morning. It survives, with a narrower scope than…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #5 · Practice › Storage & stability · 31 May 2026 · 21 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
-
The anatomy of a question that gets answered within an hour Replied, post #61 · Start Here › How to Ask · 30 May 2026 · 21 likes If the answer you got does not fit your case, say which part does not fit rather than restating the question. Otherwise the next reply is the same as the last one.
-
The best-written scientific paper you have read Replied, post #62 · Lounge › Off topic · 24 May 2026 · 1 like Understood, and I withdraw the assumption I opened with.
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #31 · Practice › Administration · 23 May 2026 · 7 likes Helpful, and short, which on this subject is harder than long.
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #42 · Practice › Dosing & titration · 21 May 2026 · 15 likes Building on post #40 rather than restating it. If symptoms reset at each step, that is the expected pattern rather than a sign that the previous adaptation was…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #45 · Analytics › HPLC & UHPLC · 18 May 2026 · 21 likes Reporting rather than recommending, on Area percent versus weight percent. What happened is above. Whether it should have is a different question and not one I am…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #62 · Clinical › Bloodwork · 9 May 2026 · 0 likes The arithmetic in post #61 is right; the assumption feeding it is the part to check. Two things can be true about Thyroid function tests during substantial at once: the…
-
Coming back to: Measurement error in a self-reported exposure Replied, post #18 · Evidence › Study critique · 25 Apr 2026 · 7 likes Whatever the answer on Measurement error turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the…
-
Spike-and-recover accuracy for a peptide assay Replied, post #27 · Analytics › Method validation · 7 Apr 2026 · 1 like Taking post #26 at face value and following it one step further. If you are new and reading this thread for the answer to spike-and-recover accuracy: the answer is…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #3 · Data & Tools › Calculators · 31 Mar 2026 · 21 likes Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed when identified. It is worth stating the boring…
-
Which fields on a certificate actually matter, ranked Replied, post #23 · Analytics › COA interpretation · 17 Mar 2026 · 11 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #62 · Practice › Interactions · 4 Mar 2026 · 8 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
Recording a dissent on a document rather than suppressing it Replied, post #6 · Documentation › Doc review · 28 Feb 2026 · 12 likes Ask what the page would look like if it were wrong. A document with no stated failure conditions is hard to review and harder to maintain. Worth one more sentence than…
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #45 · Evidence › Trials · 23 Feb 2026 · 0 likes On Reading a supplementary appendix: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable…
-
A plateau that disappeared when I changed how I measured Replied, post #16 · Outcomes › Progress reports · 16 Feb 2026 · 4 likes I think the plateau question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #59 · Outcomes › Progress reports · 15 Feb 2026 · 9 likes Practical answer on Seven-day rolling, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the…
-
Oral semaglutide bioavailability and its variability between people Replied, post #30 · Compounds › Oral incretins · 25 Jan 2026 · 13 likes Where I part company with post #28, and it is a narrow parting. Timing consistency matters more for oral dosing than for weekly injection, because absorption depends on…
-
Five questions in one post gets you one answer — how to split them Started this topic · Start Here › How to Ask · 20 Jan 2026 · 60 likes On the subject in the title: Five questions in one post gets you one answer — how to split them Working notes rather than a conclusion. A narrow question about five…
-
Request: a diff view for wiki revisions — the long version Replied, post #101 · Meta › Feature requests · 18 Jan 2026 · 18 likes Then the honest version is a comparison of the record shapes rather than the scores. How many results, over how long, from which services. That I would use. The…
-
Research-use-only labelling: what it means and what it does not Replied, post #88 · Sourcing › Regulatory · 16 Jan 2026 · 24 likes If you can confirm or contradict a position for your own region, please date the answer. An undated regional claim is the least useful thing in this category.
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #36 · Regional › UK & Ireland · 4 Jan 2026 · 0 likes Private prescribing would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #93 · Practice › Side effects · 29 Dec 2025 · 0 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #46 · Access › Pricing · 26 Dec 2025 · 1 like I have three months of notes on Price changes and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite…
-
The decimal-point error, and the habit that catches it Replied, post #99 · Practice › Reconstitution · 18 Dec 2025 · 0 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
Request: a diff view for wiki revisions — the long version Replied, post #85 · Meta › Feature requests · 16 Dec 2025 · 0 likes Community support: if other people support your request, they can reply with "+1" or "I would use that too". Widely-requested features are prioritised. Noting that the…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #69 · Compounds › Semaglutide · 14 Dec 2025 · 15 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Replied, post #2 · Compounds › Secretagogues & GH axis · 5 Dec 2025 · 0 likes What would change my mind on Evidence quality is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say…
-
Robustness: the parameters worth deliberately varying Replied, post #32 · Analytics › Method validation · 30 Nov 2025 · 31 likes Post #30 put the caveat in the right place and I want to underline it. The limit of quantitation determines what the impurity table can honestly contain. Peaks below it…
-
How to ask about something you suspect is a bad idea Replied, post #28 · Start Here › How to Ask · 25 Nov 2025 · 0 likes Say what you want out of the answer. "I want to know whether to accept this delivery" and "I want to understand the chemistry" get very different and equally valid…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #36 · Analytics › Method validation · 31 Oct 2025 · 3 likes Robustness testing deliberately varies the parameters most likely to drift — organic percentage, pH, temperature, flow — and shows the result does not. It is the part…
-
The headache that turns out to be dehydration Replied, post #26 · Nutrition & Training › Hydration & electrolytes · 17 Oct 2025 · 2 likes Narrowing post #25, because the general version has more than one answer. What I would check first on headache is whether the thing being measured moved or whether the…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #3 · Start Here › Welcome · 11 Oct 2025 · 21 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #4 · Start Here › Welcome · 7 Oct 2025 · 11 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #99 · Evidence › Preprints · 3 Oct 2025 · 7 likes Post #96 answers the question as asked. The question underneath it is different. Two claims get bundled together under Citing a preprint and they need separating. The…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #44 · Compounds › Cagrilintide & amylin analogues · 3 Oct 2025 · 23 likes This follows post #41 rather than contradicting it. On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most damage, and…
-
What a purity-only report leaves out Replied, post #29 · Sourcing › Independent verification · 29 Sep 2025 · 0 likes Offering a way to settle purity-only rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the…
-
Documenting an adverse event properly Replied, post #9 · Safety › Adverse events · 14 Sep 2025 · 1 like Confirming post #6 from a second method, which matters more than confirming it from a second person. A written record of an event with dates is what makes it assessable…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #34 · Compounds › Other compounds · 2 Sep 2025 · 0 likes Narrowing post #33, because the general version has more than one answer. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #3 · Compounds › Tirzepatide · 17 Aug 2025 · 0 likes The opening post and I disagree about the size of the effect, not about the direction. A note on scope: what I am saying about Reading SURMOUNT-1 without the press…
-
Second pass at: The mass-error checker and its intended scope Started this topic · Data & Tools › Calculators · 13 Aug 2025 · 3 likes Posting this under the heading it deserves: Second pass at: The mass-error checker and its intended scope Everything below is what sits behind that. Posting a small…
-
Revisiting: List price versus negotiated price versus what you pay Replied, post #28 · Access › Pricing · 11 Aug 2025 · 0 likes Confirming post #27 from a second method, which matters more than confirming it from a second person. The most useful pricing posts here are the ones that show the…
-
Washout: how long is long enough, and for what purpose Replied, post #37 · Pharmacology › Pharmacokinetics · 19 Jun 2025 · 0 likes Area under the curve is the exposure measure that matters for most effects in this class. Peak concentration matters more for tolerability. I have written this out at…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #137 · Access › Insurance & coverage · 16 Jun 2025 · 0 likes Adding the boring version of appeal, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary explanations, in…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #23 · Data & Tools › Calculators · 12 Jun 2025 · 7 likes Coming back to post #19, because the follow-up matters more than the original answer. On titration planner refuses: the maintained page in the documentation commons…
-
A well-designed study with a badly written abstract Replied, post #124 · Evidence › Study critique · 2 Jun 2025 · 0 likes Post #122 is the version of this I will quote in future. One addition. Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by…
-
Coming back to: Getting a referral rather than a refusal Replied, post #10 · Clinical › Prescriber conversations · 28 May 2025 · 0 likes Answering the question post #7 raises rather than the one it answers. Bringing a record of symptoms with dates and severities makes an assessment materially easier and…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #16 · Pharmacology › Pharmacokinetics · 26 May 2025 · 28 likes The failure mode on Clearance pathways is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #122 · Sourcing › Independent verification · 20 May 2025 · 5 likes Something worth flagging about Janoshik: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
-
Scheduled maintenance and what will be unavailable Replied, post #122 · Meta › Announcements · 25 Apr 2025 · 0 likes The edit is clearer. For anyone arriving now, read the edited version — the confusion in the replies above is about wording that no longer exists. I would want a second…
-
Follow-up: What other technical communities get right that we do not Replied, post #60 · Lounge › Off topic · 6 Apr 2025 · 30 likes A digression that keeps occurring to me: the most-linked documents here are the dullest ones. Nothing gets cited like the unit-arithmetic page.
-
Telehealth prescribing models in the US Replied, post #80 · Regional › North America · 5 Apr 2025 · 30 likes Date every claim in this subcategory. Positions here have moved repeatedly and old posts are read as current. Reporting the observation and leaving the explanation open…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #46 · Compounds › Secretagogues & GH axis · 23 Jan 2025 · 0 likes Hexarelin and the earlier peptidyl secretagogues have more published human data than the newer ones and a less favourable profile, which is worth knowing before…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #99 · Access › Insurance & coverage · 1 Jan 2025 · 0 likes Narrowing post #98, because the general version has more than one answer. Trying to state the Step therapy requirements position in a way that someone who disagrees…
-
A supplier that answers analytical questions with restated claims Replied, post #5 · Sourcing › Red flags · 1 Jan 2025 · 32 likes Building on post #2 rather than restating it. Being wrong in public about a supplier is costly to that supplier and to the person who was wrong. That is why the…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #39 · Compounds › Cagrilintide & amylin analogues · 22 Dec 2024 · 6 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #17 · Compounds › Semaglutide · 19 Dec 2024 · 7 likes Gallbladder events appear in the labelling for this class and are more common with larger, faster weight reduction. The mechanism is not specific to the drug — rapid…
-
Promotion criteria, and the one that stops most nominations Replied, post #127 · Documentation › Doc review · 30 Nov 2024 · 13 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #2 · Access › Insurance & coverage · 21 Oct 2024 · 13 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #65 · Practice › Administration · 29 Sep 2024 · 5 likes Alcohol swabbing and letting the site dry is the whole of the preparation for a subcutaneous injection into intact skin. Injecting before it dries is what stings.
-
Meeting a protein target on a suppressed appetite — one year on Replied, post #14 · Nutrition & Training › Protein & intake · 16 Sep 2024 · 30 likes A target that is not being met is worth adjusting downward to something achievable rather than being missed indefinitely. Worth saying I have only my own numbers here,…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #43 · Analytics › Mass spectrometry · 18 Aug 2024 · 32 likes Two people in this thread mean different things by High-resolution and are disagreeing about the definition while believing they are disagreeing about the facts. Worth…
-
Guidelines revision: what changed and why Replied, post #66 · Meta › Announcements · 27 Jul 2024 · 4 likes The edit is clearer. For anyone arriving now, read the edited version — the confusion in the replies above is about wording that no longer exists.
-
Coming back to: Pricing far outside the range, in either direction Replied, post #10 · Sourcing › Red flags · 24 Jul 2024 · 4 likes Pressure to pay outside a normal channel is the practical warning that has nothing to do with chemistry and is the one people ask about least.
-
The mass-error checker and its intended scope Replied, post #16 · Data & Tools › Calculators · 28 May 2024 · 4 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…